Please login to the form below

Not currently logged in
Email:
Password:

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO

He takes over from the UK biotech company's co-founder Michael Walker

Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO.

He replaces Michael Walker, one of the UK-based company's co-founders, who is stepping down from his position but will remain as a senior scientific advisor to the board.

Dr Karlsson was most recently a director of S*BIO, a Singapore- and US-based biotech focused on developing small molecule anti-cancer drugs.

Prior to his time at S*BIO, Dr Karlsson was executive VP of pharma global research at Bayer Healthcare and before that he held senior leadership positions at Rhone-Poulenc Rorer (now Sanofi) and Astra (now AstraZeneca).

“We have taken time to identify and recruit the right person to take over from Michael after he had notified the Board of his intention to step down,” said company chair Professor Clive Page.

“We believe Jan-Anders' experience in the pharmaceutical and biotechnology sector will be invaluable to Verona Pharma as we move our clinical programmes forward, and continue to grow and expand the company. We very much look forward to working with him.”

2nd May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics